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The initiation site for transcripotion of the 30-kDa protein mRNA of tobacco mosaic virus was mapped 
uniquely at residue 1558 from the 3 ‘-terminus on TMV RNA using the primer-extension and the 
Sl-nuclease mapping method. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
The genome of tobacco mosaic virus (TMV) is a 
single-stranded RNA molecule about 6400 
nucleotides long and codes for at least 4 proteins: 
the 130-, 180-, 30-kDa and coat proteins [l]. The 
synthesis of two of these proteins, the coat protein 
and the 30-kDa protein, is directed by respective 
subgenomic mRNAs (CP mRNA [2] and the 
30-kDa protein mRNA [3]). 
The synthesis of both subgenomic mRNAs starts 
at an early stage during infection. The 30-kDa pro- 
tein mRNA is synthesized transiently along with 
the 30-kDa protein, while CP mRNA synthesis 
continues [4]. The mechanisms of synthesis of the 
subgenomic RNAs and of shut-off of 30-kDa pro- 
tein mRNA synthesis are still unknown. 
Tobacco protoplasts were inoculated with TMV- 
RNA (common strain OM) by use of liposomes 
[6]. Total RNA was extracted from cells 6 h 
postinfection with lysis buffer as in [4] and sub- 
jected to electrophoresis on an 8 M urea-2.3% 
polyacrylamide gel. The 30-kDa protein mRNA 
was recovered from the gel as in [7]. Its messenger 
RNA activity was confirmed by in vitro translation 
in a rabbit reticulocyte lysate (Amersham) [8]. 
The CP mRNA was isolated from TMV-infected 
tobacco leaves and its sequence has been deter- 
mined [5]. Compared with the sequence of the gen- 
omit RNA, the initiation site for transcription of 
the CP mRNA has been determined to be at resi- 
due 693 from the 3 ’ -terminus of the genomic RNA. 
Here, we have determined the initiation site for 
transcription of the 30-kDa protein mRNA by the 
primer-extension method and the Sl-mapping 
method. It was located at the G base of residue 
1558 from the 3’-terminus. 
Two types of extension primers and Sl mapping 
probes were prepared as shown in fig. 1. pOM5C6 
[9] contains sequences of the 3 ‘-portion of the 
genomic RNA of TMV OM. H-S1 (nucleotide 
1940-1312 from the 3’-terminus) and B-S1 
(nucleotide 1940-1425) are probes used for Sl 
mapping. H-Pr (nucleotide 1348-1312) and B-Pr 
(nucleotide 1447-1425) are primers used for 
primer-extension analysis. H-S1 and H-Pr were 
made from a Hind111 fragment of pOMSC6, which 
was 5 ’ -end phosphorylated and subjected to diges- 
tion by HaeIII and HinfI, respectively. B-S1 and 
B-Pr are made from a BgflI fragment of pOMSC6 
which was 5 ’ -end phosphorylated and subjected to 
digestion by HaeIII and TaqI, respectively. 
The primer-extension method was performed as 
follows. 5 ‘-32P-labeled primer (0.01-0.05 pmol) 
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and the 30-kDa protein mRNA (0.5 fmol) were an- 
nealed in a sealed capillary in 0.3 M KCI, 50 mM 
Tris-Cl (pH 7.9 at 42°C) by heating at 70°C for 
10 min and cooling slowly to 30°C. The annealed 
mixture was diluted to 60 mM Tris-Cl, 10 mM 
MgCL, 10 mM DTT, 60 mM KCI, 1 mM of each 
dNTP. AMV reverse transcriptase (kindly provid- 
ed by Dr A. Ishihama) was added to the mixture at 
100 units/ml and incubated at 42°C for 45 min. 
For Sl-nuclease mapping the hybridization buf- 
fer and Sl-digestion buffer were prepared as in 
[lo]. Probes (0.05-0.2 pmol), the 30-kDa protein 
mRNA (1 fmol) and 20 pg carrier tRNA (brewer’s 
yeast) were dissolved in the hybridization buffer, 
sealed in a capillary and heated at 90°C for 
15 min. The mixture was kept at 50°C for 4 h, 
then poured into 30 vols precooled Sl digestion 
buffer. Hybrids were trimmed with Sl nuclease 
(Seikagaku Kogyo) at 1.5 units/ml at 45°C for 
30 min. 
After reverse transcription or S 1 -nuclease diges- 
tion the products were deproteinized with phenol/ 
chloroform (1: l), precipitated with 
resolved on the sequencing els [7]. 
3. RESULTS AND DISCUSSION 
ethanol and 
The 30-kDa protein mRNA is synthesized tran- 
siently only at an early stage (2-9 h) in TMV infec- 
tion [4]. Therefore, we isolated the 30-kDa protein 
mRNA from the cells 6 h postinfection and con- 
firmed its messenger RNA activity for 30-kDa pro- 
tein by in vitro translation in a reticulocyte lysate 
(not shown). 
To determine the 5 ‘-end of the 30-kDa protein 
mRNA precisely, we first carried out primer- 
extension experiments using two kinds of primers 
(fig.1). H-Pr or B-Pr was annealed with the 
30-kDa protein mRNA or the genomic RNA. The 
reverse-transcribed products were then separated 
on a sequencing el with an A + G ladder generated 
using H-S1 or B-S1 as in [7] (fig.2A). Only one 
band could be seen specific to the 30-kDa protein 
mRNA. This fact shows that he 30-kDa protein 
mRNA has no heterogeneity at the 5 ‘-end. The 
cDNAs primed by H-Pr and B-Pr had identical ter- 
mini (fig.2A). Considering that the sequencing lad- 
der moves 1.5 bases faster than the reverse- 
transcribed DNA [Ill, the 5’-terminus of the 
genomlc RNA 
30 K protein mRNA 
* ii-s1 
-* H-Pr 
f B-S1 
--* B-Pr 
Fig.1. Primers for extension analysis and probes for Sl 
nuclease mapping. pOM5C6 [9] contains equences of
the 3’-portions of the genomic RNA of TMV OM. H-S1 
and H-Pr were made from a Hind111 fragment of 
pOMSC6. The fragment was 5’-32P-labeled at the 
Hind111 site with T4 polynucleotide kinase and 
subsequently digested with Hue111 (H-Sl) and HinfI (H- 
Pr), respectively. B-S1 and B-Pr were made from a BgflI 
fragment of pOMSC6. The fragment was 5’-32P-labeled 
at the BgZII site, and then digested with HaeIIi (B-Sl) 
and TaqI (B-Pr), respectively. H-Pr and B-Pr were 
purified and the strands were separated on a 8.3 M 
urea-g% polyacrylamide gel [7]. H-S1 and B-S1 were 
purified on a 4% polyacrylamide gel and used without 
strand separation. Each fragment was 5 ‘-end labeled at 
the terminus indicated by an asterisk (antisense strand). 
The nucleotide numbers in brackets indicate the position 
of the terminus of each fragment from the 3’-end of the 
genomic RNA. 
30-kDa protein mRNA is deduced to be G at 
residue I558 from the 3 ‘-terminus. 
In the Sl-mapping method, only one band of Sl 
trimmed product was obtained specific to the 
30-kDa protein mRNA (fig.2A). The band was, 
however, a few bases longer than the reverse 
transcript of the primer-extension method. The 
mobility of the band was not affected by a variety 
of Sl nuclease concentrations (0.3-3.0 units/ml). 
To resolve this discrepancy, we checked the initia- 
tion site for transcription of the CP mRNA by 
both the primer-extension and the Sl-mapping 
method. By the primer-extension method, we 
could locate the initiation site of CP mRNA to be 
the same as reported in [12]. In the Sl-mapping 
method, however, Sl trimmed products were a few 
bases longer than the reverse transcript (fig.ZB). 
Therefore, on the basis of these results we con- 
clude that transcription of the 30-kDa protein 
mRNA initiates at residue 1558 from the 
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Fig.2. Analysis of the 5’-terminus of the 30-kDa protein mRNA (A) and CP mRNA (B) by primer-extension and Sl 
nuclease mapping analysis. A + G designate Maxam-Gilbert sequencing reactions [7] of each Sl probe (antisense strand). 
(A) The cDNA products of primer extension are shown by closed arrows. The Sl probes, which were hybridized with 
the 30-kDa protein mRNA and subsequently treated with Sl-nuclease, are shown by open arrows. The cDNA bands 
migrated 1.5 bases behind the corresponding position of G (residue 1558 from the 3’-terminus of the genomic RNA). 
The arrow head indicates the banding position presumed in [ 11. The sequences of the antisense strand are shown in the 
left array, those of sense strand are shown in the right array. The figures indicate the nucleotide number from the 
3 ‘-terminus of the genomic RNA. (B) The CP mRNA of the Cc strain was purified from rods as in [17] and analyzed 
by the Sl-mapping and the primer-extension methods. The reverse transcript was unique, while the bands of Sl trimmed 
probe DNA were multiple probably due to transient breaking of base pairs at the end of the RNA : DNA hybrid during 
Sl nuclease digestion [18]. 
3 ’ -terminus. Previously, authors in [ 131 reported 
that steric hindrance by the cap group caused the 
few deoxynucleotides corresponding to the region 
upstream of the 5 ‘-terminus of the RNA to be 
resistant to Sl nuclease in the case of ,&globin 
mRNA. The retardation of the mobility of the 
Sl -trimmed product might suggest he existence of 
the cap structure in the 30-kDa protein mRNA. On 
the other hand, authors in [14] and [ 151 reported 
that the 12 RNA appears to be uncapped. We tried 
to analyze chemically the 5 ‘-terminal structure of 
the 30-kDa mRNA by labeling with vaccinia cap- 
ping enzyme and [~u-~~P]GTP with or without prior 
&elimination. However, the amount of the 30-kDa 
protein mRNA was so small that we could draw no 
conclusions on this point. 
The initiation site for transcription of the 
30-kDa protein mRNA is 65 nucleotides upstream 
from the AUG initiation codon of the 30-kDa pro- 
tein cistron. Previously, we found a homology bet- 
ween the sequence around the capping site of the 
CP mRNA and the sequence upstream from the 
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the 30K protein rnRNA 
/-+ 
1 
the coat protem mHNA 
Fig.3. Comparison of the bordering regions of initiation 
sites for transcription of the two subgenomic RNAs on 
the genomic RNA. G bases in the black boxes are the 
initiation sites for transcription of each subgenomic 
RNA. Initiation codons are underlined. The closed 
arrow and the open arrow under the sequences indicate 
the positions we [I43 and authors in [I] have predicted, 
respectively, as the initiation sites for tr~scription of 
the 30-kDa protein mRNA. The distances from the 
3’-end are indicated in nucleotides. 
30-kDa protein cistron and predicted that residue 
1558 from the 3 ‘-terminus might be the initiation 
site for transcription of the 30-kDa protein mRNA 
[la] (fig.3). The site of initiation of the 30-kDa 
protein mRNA was identical to our prediction. As 
shown in fig.3, both sequences hare a common 
feature: A + U are abundant downstream of the in- 
itiation site and G+C are abundant upstream of 
the site. Although the mechanism of synthesis of 
the two subgenomic RNAs is still unknown, the se- 
quences mentioned above possibly contain the 
recognition signal for the enzyme(s) which would 
participate in subgenomic RNA synthesis. 
On the other hand, authors in [l] paid attention 
to a short U-i-A rich sequence, referred to as a 
‘Butler box’, on the genomic RNA preceding the 
5 ‘-end of the CP mRNA. By analogy to the CP 
mRNA, they predicted that the G at nucleotide 
1501 from the 3 ‘-terminus could be the initiation 
site for transcription of the 30-kDa protein mRNA 
[l] (fig.3). Since we found no RNA species 1501 
nucleotides long (fig.ZA), the Butler box appears 
not to be significant in determining the initiation 
of transcription of the 30-kDa protein mRNA. 
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